{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:57:21Z","timestamp":1793750241306,"version":"4.6.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010023","name":"Natural Science Research of Jiangsu Higher Education Institutions of China","doi-asserted-by":"publisher","award":["19KJA350001"],"award-info":[{"award-number":["19KJA350001"]}],"id":[{"id":"10.13039\/501100010023","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.biopha.2022.113291","type":"journal-article","created":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T06:50:25Z","timestamp":1655362225000},"page":"113291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Hydroxyurea protects against diabetic cardiomyopathy by inhibiting inflammation and apoptosis"],"prefix":"10.1016","volume":"153","author":[{"given":"Yu","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiulun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.biopha.2022.113291_bib1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrendo.2014.29","article-title":"Insulin resistance and hyperglycaemia in cardiovascular disease development","volume":"10","author":"Laakso","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"issue":"9","key":"10.1016\/j.biopha.2022.113291_bib2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","article-title":"Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence","volume":"17","author":"Tan","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"4","key":"10.1016\/j.biopha.2022.113291_bib3","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","article-title":"Molecular mechanisms of diabetic cardiomyopathy","volume":"57","author":"Bugger","year":"2014","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.biopha.2022.113291_bib4","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrendo.2015.216","article-title":"Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy","volume":"12","author":"Jia","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113291_bib5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41401-020-0490-7","article-title":"Sirtuin 3 deficiency exacerbates diabetic cardiomyopathy via necroptosis enhancement and NLRP3 activation","volume":"42","author":"Song","year":"2021","journal-title":"Acta Pharm. Sin."},{"issue":"14","key":"10.1016\/j.biopha.2022.113291_bib6","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1093\/cvr\/cvz014","article-title":"FoxO1 inhibits autophagosome-lysosome fusion leading to endothelial autophagic-apoptosis in diabetes","volume":"115","author":"Zhang","year":"2019","journal-title":"Cardiovasc Res"},{"issue":"2","key":"10.1016\/j.biopha.2022.113291_bib7","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/bjh.17323","article-title":"Absence of hydroxyurea-induced mutational effects supports higher utilisation for the treatment of sickle cell anaemia","volume":"194","author":"Ware","year":"2021","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.biopha.2022.113291_bib8","doi-asserted-by":"crossref","first-page":"R630","DOI":"10.1152\/ajpregu.00205.2020","article-title":"Hydroxyurea improves nitric oxide bioavailability in humanized sickle cell mice","volume":"320","author":"Taylor","year":"2021","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.biopha.2022.113291_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.666339","article-title":"Therapeutic dose of hydroxyurea-induced synaptic abnormalities on the mouse spermatocyte","volume":"12","author":"Fan","year":"2021","journal-title":"Front Physiol."},{"issue":"10","key":"10.1016\/j.biopha.2022.113291_bib10","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1042\/CS20160491","article-title":"Are targeted therapies for diabetic cardiomyopathy on the horizon?","volume":"131","author":"Tate","year":"2017","journal-title":"Clin. Sci. (Lond. )"},{"key":"10.1016\/j.biopha.2022.113291_bib11","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3389\/fphys.2018.01514","article-title":"Diabetic cardiomyopathy: current and future therapies. Beyond glycemic control","volume":"9","author":"Borghetti","year":"2018","journal-title":"Front Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113291_bib12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/cvr\/cvy226","article-title":"Telmisartan and thiorphan combination treatment attenuates fibrosis and apoptosis in preventing diabetic cardiomyopathy","volume":"115","author":"Malek","year":"2019","journal-title":"Cardiovasc Res."},{"issue":"2","key":"10.1016\/j.biopha.2022.113291_bib13","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41419-017-0093-5","article-title":"Inhibition of p53 prevents diabetic cardiomyopathy by preventing early-stage apoptosis and cell senescence, reduced glycolysis, and impaired angiogenesis","volume":"9","author":"Gu","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2022.113291_bib14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.mvr.2016.04.002","article-title":"Heme changes HIF-alpha, eNOS and nitrite production in HUVECs after simvastatin, HU, and ascorbic acid therapies","volume":"106","author":"da Guarda","year":"2016","journal-title":"Micro Res."},{"issue":"2","key":"10.1016\/j.biopha.2022.113291_bib15","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1046\/j.1365-2141.2002.03274.x","article-title":"Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease","volume":"116","author":"Gladwin","year":"2002","journal-title":"Br. J. Haematol."},{"issue":"13","key":"10.1016\/j.biopha.2022.113291_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133294","article-title":"Modulation of nitric oxide synthases by oxidized LDLs: Role in Vascular inflammation and atherosclerosis development","volume":"20","author":"Gliozzi","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2022.113291_bib17","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.actbio.2021.07.048","article-title":"S-nitroso human serum albumin as a nitric oxide donor in drug-eluting vascular grafts: Biofunctionality and preclinical evaluation","volume":"134","author":"Enayati","year":"2021","journal-title":"Acta Biomater."},{"issue":"4","key":"10.1016\/j.biopha.2022.113291_bib18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ajh.20129","article-title":"Increased levels of soluble ICAM-1 in the plasma of sickle cell patients are reversed by hydroxyurea","volume":"76","author":"Conran","year":"2004","journal-title":"Am. J. Hematol."},{"issue":"7","key":"10.1016\/j.biopha.2022.113291_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/genes12071096","article-title":"Hydroxyurea-the good, the bad and the ugly","volume":"12","author":"Musialek","year":"2021","journal-title":"Genes"},{"issue":"21","key":"10.1016\/j.biopha.2022.113291_bib20","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1182\/blood-2017-03-771857","article-title":"Adverse effect of hydroxyurea on spermatogenesis in patients with sickle cell anemia after 6 months of treatment","volume":"130","author":"Berthaut","year":"2017","journal-title":"Blood"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222006801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222006801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T11:48:53Z","timestamp":1779968933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222006801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":20,"alternative-id":["S0753332222006801"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113291","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydroxyurea protects against diabetic cardiomyopathy by inhibiting inflammation and apoptosis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113291","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113291"}}